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doi:10.1016/j.ejvs.2010.10.018Abstract Objectives and Design: The aim of the study was to document the radiation doses
to patients during the implantation of stents in various arteries and to discuss potential reasons
for prolongation of radiological procedures.
Materials and Methods: Measurements of air kerma (Gy) and doseearea product (Gy cm2) (DAP)
were carried out simultaneously on a sample of 345 patients, who underwent different inter-
ventional radiological procedures involving angioplasty with stenting of 73 carotid (21.5%), 22
renal (6.5%), 160 iliac (45%), 63 femoral (18.6%) and 27 popliteal (7.9%) arteries.
Results: The highest mean air kerma values for fluoroscopy and exposure were found for renal
angioplasty (340 and 420 mGy, respectively). With regard to total DAP values, the highest were
obtained for renal (148 Gy cm2) and iliac/The Inter-Society Consensus for Management of
Peripheral Arterial Disease (TASC) II C (199 Gy cm2) stent implantation. The lowest values were
for carotid (53 Gy cm2), iliac/TASC II A (6.3 Gy cm2) and femoral/TASC II A (53 Gy cm2) arteries.
For 3.5% of the patients, the air kerma was between 1 and 1.5 Gy and for 1.5%, it was between
1.5 and 2 Gy.education questions on this paper, please go to www.vasculareducation.com and click on ‘CME’.
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Radiation Doses During Stents Implantation 373Conclusions: In procedures performedon thearteries of the lower limbs, a significantly higher dose
was received by patients with TASC II C lesions. With regard to the number of stents implanted, the
totalDAPvaluewas50%higher forsimultaneous three-stent implantationthan foroneortwostents.
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Ionising radiation exposure is an inherent component of
endovascular surgery. As procedures become more complex,
greater radiation exposure is incurred by both staff and
patients. Ionising radiation carries an oncogenic risk that is
linearly related to the dose.1 Stochastic effects, such as
mutations, can result in cancer and hereditary effects.
Deterministic effects, such as cell killing, can be more
immediate and have a threshold above which severity
increases with radiation dose. Air kerma (AK), measured in
Gy, indexes the amount of radiation at a point in space and
assesses the hazard at that specific location. AKmultiplied by
the cross-sectional area of the X-ray beam at the point of
measurement yields thedoseeareaproduct (DAP), expressed
as Gy cm2. The DAP has the advantage of being constant at
any distance from the tube focus; hence,wherever the DAP is
measured, it reflects theAK radiationfield size product at the
patient’s skin. The DAP might also be useful for estimating
theeffective doseby calculating the total energy imparted to
the patient, which can then be used to calculate the
stochastic risk as a potential quality indicator.1
There has been a considerable body of work on the radi-
ation dose administered to patients during invasive cardi-
ology procedures; however, less is known about the radiation
doses incurred by patients during peripheral vascular endo-
vascular procedures. The main purpose of this study was to
detect the doses patients received during the implantation of
stents in carotid, renal, iliac, femoral and popliteal arteries
that are used as a non-surgical alternative for patients with
prohibitively high surgical risk. The angioplasty of various
peripheral arteries is an essential part of the practice of
interventional radiology. The number and complexity of
endovascular procedures have increased in recent years.2e22
Materials and Methods
In this study, measurements of AK and DAP were simulta-
neously carried out from May 2006 to September 2008 on
a sample of 345 adult patients (246 males and 99 females;
mean age: 64  SD 11), who underwent five different inter-
ventional procedureswith stent implantation (one stent: 266
patients, two stents: 57 and three stents: 22). Radiation
doses were controlled and analysed retrospectively. All
clinical procedures were performed in an operating C-arm
unit (Allura, Philips Medical Systems, Best, The Netherlands)
using pulsating X-ray radiation. Available image-intensifier
field sizes were 17 cm, 23 cm and 31 cm. The patients were
placed on an operating table with a floating tabletop. In the
C-arm unit, dose data were calculated from exposure values
andexpressedas DAP (Gy cm2) andAK (Gy), togetherwith the
total time of fluoroscopy (real-time images: stent place-
ment, min) and exposure (X-ray images taken during theinjection of contrast medium, ms). Contrast medium was
administered during image acquisition to make vessel
morphology assessment possible. During exposure time, the
patient received a higher radiation dose than during fluo-
roscopy because higher Peak kilovoltage (kVp) was required
in this procedure to get better, higher-contrast imaging.
Usually, the difference between the doses received in
the two procedures averages from 20 kVp in abdominal
examination to 40 kVp in limb examination. Accordingly, in
some cases, patients exposed for a prolonged time during
fluoroscopy with a short exposure time could receive
a smaller dose of radiation than patients exposed to a short
fluoroscopy time and a longer exposure time.
During the fluoroscopic examinations, the positioning of
the patient was observed and average values for tube
potential were noted for each projection by observing the
acquisition display.
Carotid artery stents were implanted in 73 patients,
including 24 (33%) asymptomatic patients. Patients had more
than 70% internal carotid stenosis. One to three stents,
7e12 mm in diameter and 20e60 mm in length (Precise
Control Stent Cordis Corp. NJ, USA; carotidwall stent, Boston
Scientific, MA, USA; and carotid wallstent, Acculinc Stent,
Abbott Laboratories, IL, USA) were implanted.
Renal artery stenting was indicated in 22 patients who
failed medical treatment and had stenosis of the artery of
more than 70%. Seventeen stenosed lesions of the renal
artery were located in the proximal segment, four were in
the middle segment and one in the distal segment. After
performing the angioplasty, stents were assembled on
balloons, 5e7 mm in diameter and 12e25 mm in length
(Genesis, Cordis Corp, NJ, USA), and implanted.
The 160 patients with stenosis or occlusion of the iliac
artery, who underwent angioplasty with stenting, were
grouped according to the Inter-Society Consensus for
Management of Peripheral Arterial Disease (TASC II)23 into
three morphological groups: type A, n Z 42 (27%) type B,
nZ 52 (33%) and type C, nZ 66 (40%) patients. There were
no indications for stenting in the type D classification
among our patients.23
Sixty-three patients with stenosis or occlusion of the
superficial femoral artery underwent angioplasty or sub-
intimal angioplasty with stenting. These patients were also
divided into three TASC II classification groups: type A,
n Z 16 (25%), type B, n Z 20 (31%) and type C and n Z 27
(43%) patients.
Angioplasty with stenting of the popliteal artery was per-
formed in 27 patients (24 with stenosis and three with occlu-
sion). Nitinol self-expanding stents, 6e8 mm in diameter and
20e40mm in length (Smart, Cordis Corp, NJ, USA) were used.
The objective of the study was to analyse radiation
doses in patients undergoing stenting procedures in various
arteries, and to discuss potential reasons for prolongation
of radiological procedures.
Table 1 Types of angiographic procedures and sample size, doseearea product (DAP) values [Gy cm2] and air kerma [mGy].
Total air kerma [mGy] Total DAP [Gy cm2] Fluoroscopy time [s] Exposure time [ms]
Endovascular
procedure
Tasc
II
Sample
size
Mean
(median)
Standard
deviation
(interquartile
range)
Mean
(median)
Standard
deviation
(interquartile
range)
Mean
(median)
Standard
deviation
(interquartile
range)
Mean
(median)
Standard
deviation
(interquartile
range)
Illiac artery
stenting (IAS)
A 42 156
(126)
87
(103e194)
53
(43)
28
(29e76)
329
(279)
305
(174e357)
114
(98)
77
(59e139)
B 52 417
(345)
289
(258e508)
132
(99)
114
(67e137)
463
(393)
304
(234e592)
276
(230)
204
(162e304)
C 66 662
(591)
369
(385e844)
199
(162)
114
(127e261)
728
(540)
699
(366e792)
418
(362)
233
(249e553)
Femoral artery
stenting (FAS)
A 16 33
(31)
12
(22e40)
6.3
(6)
2.7
(4e8)
445
(414)
169
(333e553)
12
(8)
8
(6e19)
B 20 61
(64)
13
(48e70)
15.5
(11.7)
10.8
(8e18)
636
(574)
301
(405e810)
24
(22)
14
(14e36)
C 27 250
(168)
234
(104e330)
70
(46)
54
(28e103)
873
(789)
434
(600e1023)
131
(58)
203
(37e138)
Carotid artery
stenting (CAS)
e 73 317
(273)
190
(196e429)
53
(42)
42
(25e67)
907
(792)
447
(618e1038)
437
(209)
443
(68e731)
Renal artery
stenting (RAS)
e 22 687
(658)
278
(454e820)
148
(145)
66
(96e207)
885
(693)
547
(576e1206)
767
(588)
670
(387e841)
Popliteal artery
stenting (PAS)
e 27 296
(203)
224
(72e131)
63
(46)
54
(14e48)
847
(762)
388
(576e1374)
474
(145)
642
(26e81)
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Statistical analysis was carried out using the statistical
package in Python (open source software). Patient doses
and exposures were separately analysed with the Krus-
kaleWallis test (H-test), according to subgroups regarding
TASC II classification and the number of stents implanted. A
p-value 0.05 was considered significant.
Results
The longest duration of fluoroscopy was for carotid, renal,
femoral-TASC II C and popliteal angioplasty (Table 1).
However, the mean (median) exposure time (X-ray images
taken during the injection of contrast medium) for renal
stent implantation was the highest at 767 ms (588 ms).
Significant differences for fluoroscopy and exposure times
were found between TASC II in angioplasty of both the
femoral (H Z 15.6, 2 df, p < 0.0004 and H Z 32.5, 2 df,
p < 0.0001, respectively) and iliac arteries (HZ 32.6, 2 df,
p < 0.0001 and HZ 67.5, 2 df, p < 0.0001, respectively). It
should be noted that significant differences have been
found for TASC II A versus B, TASC II A versus C and TASC II B
versus C for both the angioplasty procedures. TASC II C
lesions required double the duration of fluoroscopy
compared with TASC II A in both angioplasty of the femoral
artery and angioplasty of the iliac artery (Fig. 1). The
exposure time in the iliac artery of TASC II C lesions was
four times longer than for TASC II A lesions; in the case of
the femoral artery, the TASC II C/TASC II A ratio was 10.
The highest mean AK values were found for renal, carotid
and iliac TASC II B and C angioplasties. The lowest value
was found for femoral-TASC II A. With regard to total mean
(median) DAP values, the highest values were obtained forstent implantation of the renal artery at 148 Gy cm2
(145 Gy cm2) and the iliac artery/TASC II C at 199 Gy cm2
(162 Gy cm2). The lowest values were for stent implanta-
tion of the carotid artery at 53 Gy cm2 (42 Gy cm2), the
iliac artery/TASC II A at 53 Gy cm2 (43 Gy cm2), the femoral
artery/TASC II A at 6 Gy cm2 (6 Gy cm2) and the femoral
artery/TASC II B 15.5 Gy cm2 (11.7 Gy cm2).
In terms of the number of stents implanted in a single
patient, the mean (median) DAP was about 50% higher for
the implantation of three stents at 153 Gy cm2 (145 Gy cm2)
compared with one stent at 92 Gy cm2 (101 Gy cm2) or two
stents at 101 Gy cm2 (110 Gy cm2). The p-value was on
the border of significance (H Z 5.6, 2 df, p Z 0.06). In
particular, a significant difference was obtained in the case
of implantation of one versus three stents (p Z 0.02).
Despite the fact that the mean (median) AK for the
implantation of three stents at 512 Gy cm2 (459 Gy cm2) was
higher than for one at 353 Gy cm2 (343 Gy cm2) or two at
355 Gy cm2 (368 Gy cm2), the analysis indicated no signifi-
cant differences between these parameters (HZ 2.1, 2 df,
pZ 0.34). All individual differences: one versus two stents,
one versus three stents and two versus three stents were
statistically non-significant (p > 0.05).
In all procedures, imaging was performed with a rotation
angle of 0, and only renal and carotid stenting required
imaging at different angles (rotation 90: 34.9% and 48.7%
of the total number of runs, respectively). Most of the
series (79%) was acquired using 70 kVp voltage.Discussion
The potential for high patient radiation doses during
interventional radiological procedures is well known.24
A simple chest X-ray exposes a patient to a radiation dose
Figure 1 Mean radiation time, air kerma and Dose Area Product (DAP) values for fluoroscopy and exposure in iliac artery stenting
(IAS) and femoral artery stenting (FAS) by TASC II type A, B and C groups (95% confidence intervals, ) - extreme outliers,  - mild
outliers).
Radiation Doses During Stents Implantation 375of about 0.1 mGy, compared with 0.01 mGy for a dental X-
ray. The highest permitted dose for a radiation worker
amounts to 100 mGy over 5 years. By contrast, therapeutic
exposures involve much higher doses precisely delivered to
the volume of a tumour (prescribed doses are typically in
the range of 20e60 Gy). Radiation sickness results when
humans are exposed to more than a 1 Gy dose of ionising
radiation. Doses greater than 6 Gy are generally not treated
successfully and usually result in death within 2 days to 2e3
weeks, depending on the duration of the exposure.24e26
Angioplasty of the carotid, renal, iliac, femoral and
popliteal arteries are common endovascular proceduresperformed routinely in most interventional radiology insti-
tutes. The available data suggest that the radiation expo-
sure during endovascular aneurysm repair involves some of
the highest radiation doses.27 In our study, for 3.5% of the
patients, the AK was between 1 and 1.5 Gy (six patients
with an iliac stent, four with a renal stent and one for
carotid and popliteal stent implantation) and, for 1.5%, it
was between 1.5 and 2 Gy (only during angioplasty of the
iliac artery). Each of these patients was monitored for 3
months post-procedurally to look for the appearance of
radiation sickness. No individual presented any suspected
signs or symptoms, probably because the highest level of
376 N. Majewska et al.irradiation was observed among long-lasting multi-stenting
procedures. Despite this, we assume that endovascular
procedures exposing patients to doses greater than 1 Gy
can be risky and should be applied only if necessary from
a life- or limb-saving point of view. The aforementioned
patients are still under observation to assess possible late
post-irradiatory complications. In contrast to these cases,
more than 50% of all patients, who received a radiation
dose between 100 and 500 mGy, revealed no side effects.
Because the patient’s dose has a linear relationship with
radiation time, the most important issue is the reason for
using a procedure involving prolonged radiation exposure,
as discussed below.
Carotid artery stenting
Internal carotid arteries are highly sensitive tomanipulations
with a guide wire or cerebral protection systems. Rough
manoeuvres can lead to vasospasm and require treatment
with vasodilators accompanied by control angiographies
every few minutes until the problem is resolved.
The main reason for the implantation of more than one
stent was the imprecise assessment of the required stent
length or dissection after the deployment of the first stent.
Endovascular interventionists should abide by the basic
tenet of radiation protection: as low as reasonably practi-
cable (ALARP) to achieve the necessary result.
Renal artery stenting
Difficult lesions in renal arteries, located just before the
bifurcation of the artery, required placing two guide wires
in such a way as to secure the branches in case the plaque is
moved during angioplasty into one of them.
Iliac, femoral and popliteal arteries stenting
One of the reasons for prolonging the stenting procedure of
the common iliac artery, especially in its proximal segment,
was the detachment of the atherosclerotic plaque in the
bifurcation of the aorta. As a consequence, the plaque
occluded or narrowed the contralateral common or
external iliac artery, which required placing another stent
to secure the plaque and restore the flow.
During angioplasty of the superficial femoral artery, we
often experienced flow-limiting intimal dissection that had
to be remedied with stent implantation, and this contrib-
uted to an increase in radiation dose.
Heavily calcified lesions occluding the popliteal artery
sometimes required the use of different guide wires and
catheters. Even the use of these time-consuming manoeu-
vres can prove unsuccessful; hence, an interventionist has
to make a reasonable decision as to when to stop the
procedure.
The largest exposures in our study were generated by the
renal revascularisationprocedures.Given that theAngioplasty
and Stenting for Renal Artery Lesions (ASTRAL) trial showed
little or no benefit of endovascular procedures plus medical
therapy over medical therapy alone in patients with athe-
roslerotic renovascular disease, it seems reasonable that renal
angioplasty shouldbe limited toonly certain groupsofpatientswith severe renal artery stenosis (e.g., those presenting with
‘flash’ pulmonary oedema28 or acute kidney injury29).
Iliac and femoral artery stenting procedures in patients
with mild-to-moderate lesions (TASC A and B) required rela-
tively low radiation doses. This fact, togetherwith the results
obtained in the mild-to-moderate intermittent claudication
(MIMIC) study,30whereadjuvantbenefitofPTA (percutaneous
transluminal angioplasty) over supervised exercise and best
medical therapy in the treatment of intermittent claudica-
tionwereassessed,undoubtedly justifiesexposingpatients to
certain amounts of radiation: initial claudication distance
(ICD) and absolute walking distance (AWD) were significantly
improved in the group treated with PTA.
Although the DAP and radiation times are useful parame-
ters for comparing patient exposures, this comparison is
complicated by the dependency of the DAP on a number of
equipment-related factors, including beam collimation,
servicing, filter usage, movement capabilities of the X-ray
source, fluoroscopic specifications (pulse rate, acquisition
frame rate and acquisition input dose rates), X-ray photon
energy spectra, the position of the projection and potential
variations in the skill of the radiologist.31 Several recom-
mendations have been made to minimise the radiation dose
incurred during coronary angiography, including keeping
fluoroscopy use to a minimum and using low doses (pulsed
modeswhere possible), using the smallest possible number of
runs with the lowest possible number of frames and placing
the patient as far as possible from the X-ray source.1,31 As
stent implantation seems to involve similar radiation expo-
sure, these recommendations could equally be applied to the
endovascular suite. However, further studies concerning
radiation doses in different medical centres (using different
apparatus) and during treatment executed by various radi-
ologists should be conducted.
Conclusion
This study has presented radiation doses during the implan-
tation of stents in the carotid, renal, iliac, femoral and
popliteal arteries studiedwith regard to the number of stents
implanted. This study supports the following conclusions:
 Mostpatients (55%) receiveda relatively lowradiationdose
(100e500 mGy); in 3.5% of patients the AK was between 1
and 1.5 Gy and, for 1.5%, it was between 1.5 and 2 Gy;
 The highest total mean AK values were found for renal
and iliac TASC II C angioplasties (687 and 662 mGy,
respectively). The lowest mean AK value was found for
femoral stent implantation (33 mGy);
 With regard to the number of stents implanted in
a single patient, the mean DAP value was 50% higher for
a simultaneous three-stent implantation than for one or
two stents; in such cases, the mean radiation dose was
higher than 0.5 Gy and the maximum reached 1.7 Gy;
the use of one long stent instead of three stents to
reduce radiation exposure should be investigated.Conflict of Interest/Funding
None.
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